相关实验视频
Updated: Jun 26, 2025

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
2023年临床心脏病学的进步:关键临床试验的总结
Patrick Savage1, Brian Cox2, Michael Shahmohammadi2
1Craigavon Cardiology Department, Southern Health and Social Care Trust, Craigavon, Northern Ireland, UK. psavage05@qub.ac.uk.
从2023年开始的心脏病学试验为急性冠状动脉综合征,结构性干预和心力衰竭管理提供了新的见解. 关键研究强调了抗血小板治疗,透导管干预和心房的治疗方面的进展.
科学领域:
- 心血管医学 心血管医学
- 临床心脏病学 临床心脏病学
- 干预心脏病学 干预心脏病学
背景情况:
- 2023年,许多重要的临床试验在主要的心脏病学会议上发表.
- 这些试验为临床心脏病学提供了有价值的贡献和潜在的改变实践的见解.
研究的目的:
- 总结2023年发表或提交的关键临床心脏病学试验.
- 思考这些最近的试验的临床背景和影响.
主要方法:
- 在2023年主要的心脏病学会议上提出的临床试验的综合审查.
- 纳入标准侧重于具有广泛相关性和有可能改变现行实践的试验.
主要成果:
- 确定了80项关键试验,涵盖急性冠状动脉综合征 (ACS),干预性心脏病学,结构性干预,心力衰竭 (HF) 和电生理学.
- 值得注意的试验包括对抗血小板管理 (HOST-IDEA,T-PASS),干预程序 (ORBITA 2),支架技术 (BIOSTEMI),横管大动脉干预 (TAVI),横管三管干预 (TRISCEND II),高频率研究 (DAPA-MI) 和心房动 (AF) 移除 (PULSED AF,ADVENT) 的试验.
结论:
- 该审查提供了2023年关键心脏病学试验的摘要.
- 这些信息对实践临床医生和该领域的研究人员来说都很重要.
更多相关视频
02:47Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
Published on: May 12, 2023
14:24Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
相关概念视频
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Preclinical Development: Overview